Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risk factors of uncontrolled chronic spontaneous urticaria symptoms in children treated with standard-dose second-generation H1 antihistamines
TCTR20190720005Completed
- Sponsor
- Songklanagarind Hospital
- Start
- Aug 2018
- Countries
- 1
01
Overview
Open-label, single-arm trial in chronic idiopathic urticaria (CIU), sponsored by Songklanagarind Hospital. Primary endpoint: Uncontrolled urticaria symptoms under standard-dose second-generation H1 antihistamines. Started Aug 2018; status: completed.
02
Conditions
chronic idiopathic urticaria (CIU)
Beyond the preview
Go deeper on TCTR20190720005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20190720005.